GrippeEspagneV1, Main, Exploration, bibRecord, 000066

Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.

Identifieur interne : 000066 ( Main/Exploration ); précédent : 000065; suivant : 000067

Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.

Auteurs : Clara Mazagatos [Espagne] ; Concepci N Delgado-Sanz [Espagne] ; Jesús Oliva [Espagne] ; Alin Gherasim [Espagne] ; Amparo Larrauri [Espagne]

Source :

PloS one [ 1932-6203 ] ; 2018.

RBID : pubmed:30089148

Descripteurs français

KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Bases de données factuelles (MeSH), Complications de la grossesse (immunologie), Complications infectieuses de la grossesse (épidémiologie), Couverture vaccinale (MeSH), Espagne (épidémiologie), Facteurs de risque (MeSH), Femelle (MeSH), Femmes enceintes (MeSH), Grippe humaine (complications), Grippe humaine (épidémiologie), Grossesse (MeSH), Hospitalisation (MeSH), Humains (MeSH), Vaccination (MeSH), Vaccins antigrippaux (effets indésirables), Vaccins antigrippaux (pharmacologie), Études rétrospectives (MeSH).
MESH :
- effets indésirables : Grippe humaine, Vaccins antigrippaux.
- immunologie : Complications de la grossesse.
- pharmacologie : Vaccins antigrippaux.
- épidémiologie : Complications infectieuses de la grossesse, Espagne, Grippe humaine.
- Adolescent, Adulte, Bases de données factuelles, Couverture vaccinale, Facteurs de risque, Femelle, Femmes enceintes, Grossesse, Hospitalisation, Humains, Vaccination, Études rétrospectives.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Adolescent (MeSH), Adult (MeSH), Databases, Factual (MeSH), Female (MeSH), Hospitalization (MeSH), Humans (MeSH), Influenza Vaccines (adverse effects), Influenza Vaccines (pharmacology), Influenza, Human (complications), Influenza, Human (epidemiology), Pregnancy (MeSH), Pregnancy Complications (immunology), Pregnancy Complications, Infectious (epidemiology), Pregnant Women (MeSH), Retrospective Studies (MeSH), Risk Factors (MeSH), Spain (epidemiology), Vaccination (MeSH), Vaccination Coverage (MeSH).
MESH :
- chemical , adverse effects : Influenza Vaccines.
- chemical , pharmacology : Influenza Vaccines.
- geographic , epidemiology : Spain.
- complications : Influenza, Human.
- epidemiology : Influenza, Human, Pregnancy Complications, Infectious.
- immunology : Pregnancy Complications.
- Adolescent, Adult, Databases, Factual, Female, Hospitalization, Humans, Pregnancy, Pregnant Women, Retrospective Studies, Risk Factors, Vaccination, Vaccination Coverage.

Abstract

Based on previous observations during pandemics and seasonal epidemics, pregnant women are considered at risk of developing severe influenza outcomes after influenza infection. With the aim of preventing severe influenza illness, the World Health Organization (WHO) includes pregnant women as a target group for seasonal influenza vaccination. However, influenza vaccine uptake during pregnancy remains low in many countries, including Spain. The objectives of this study were to increase the evidence of pregnancy as a risk factor for severe influenza illness and to study the potential role of seasonal influenza vaccination in the prevention of severe outcomes in infected pregnant women. Using information from the surveillance of Severe Hospitalized Confirmed Influenza Cases (SHCIC) in Spain, from seasons 2010/11 to 2015/16, we estimated that pregnant women in our study had a relative risk of hospitalization with severe influenza nearly 7.8 times higher than non-pregnant women of reproductive age. Only 5 out of 167 pregnant women with known vaccination status in our study had been vaccinated (3.6%). Such extremely low vaccination coverage only allowed obtaining crude estimates suggesting a protective effect of the vaccine against influenza complications (ICU admission or death). Our overall results support that pregnant women could benefit from seasonal influenza vaccination, in line with national and international recommendations.

DOI: 10.1371/journal.pone.0200934
PubMed: 30089148
PubMed Central: PMC6082521

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 00046
to stream Main, to step Curation: 000046

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.</title>
<author><name sortKey="Mazagatos, Clara" sort="Mazagatos, Clara" uniqKey="Mazagatos C" first="Clara" last="Mazagatos">Clara Mazagatos</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Delgado Sanz, Concepci N" sort="Delgado Sanz, Concepci N" uniqKey="Delgado Sanz C" first="Concepci N" last="Delgado-Sanz">Concepci N Delgado-Sanz</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Oliva, Jesus" sort="Oliva, Jesus" uniqKey="Oliva J" first="Jesús" last="Oliva">Jesús Oliva</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gherasim, Alin" sort="Gherasim, Alin" uniqKey="Gherasim A" first="Alin" last="Gherasim">Alin Gherasim</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Larrauri, Amparo" sort="Larrauri, Amparo" uniqKey="Larrauri A" first="Amparo" last="Larrauri">Amparo Larrauri</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30089148</idno>
<idno type="pmid">30089148</idno>
<idno type="doi">10.1371/journal.pone.0200934</idno>
<idno type="pmc">PMC6082521</idno>
<idno type="wicri:Area/Main/Corpus">00046</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00046</idno>
<idno type="wicri:Area/Main/Curation">000046</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000046</idno>
<idno type="wicri:Area/Main/Exploration">000046</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.</title>
<author><name sortKey="Mazagatos, Clara" sort="Mazagatos, Clara" uniqKey="Mazagatos C" first="Clara" last="Mazagatos">Clara Mazagatos</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Delgado Sanz, Concepci N" sort="Delgado Sanz, Concepci N" uniqKey="Delgado Sanz C" first="Concepci N" last="Delgado-Sanz">Concepci N Delgado-Sanz</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Oliva, Jesus" sort="Oliva, Jesus" uniqKey="Oliva J" first="Jesús" last="Oliva">Jesús Oliva</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gherasim, Alin" sort="Gherasim, Alin" uniqKey="Gherasim A" first="Alin" last="Gherasim">Alin Gherasim</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Larrauri, Amparo" sort="Larrauri, Amparo" uniqKey="Larrauri A" first="Amparo" last="Larrauri">Amparo Larrauri</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Databases, Factual (MeSH)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza Vaccines (adverse effects)</term>
<term>Influenza Vaccines (pharmacology)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Pregnancy (MeSH)</term>
<term>Pregnancy Complications (immunology)</term>
<term>Pregnancy Complications, Infectious (epidemiology)</term>
<term>Pregnant Women (MeSH)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Vaccination (MeSH)</term>
<term>Vaccination Coverage (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Bases de données factuelles (MeSH)</term>
<term>Complications de la grossesse (immunologie)</term>
<term>Complications infectieuses de la grossesse (épidémiologie)</term>
<term>Couverture vaccinale (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Femmes enceintes (MeSH)</term>
<term>Grippe humaine (complications)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Grossesse (MeSH)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Vaccination (MeSH)</term>
<term>Vaccins antigrippaux (effets indésirables)</term>
<term>Vaccins antigrippaux (pharmacologie)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Grippe humaine</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
<term>Pregnancy Complications, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Complications de la grossesse</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Pregnancy Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Complications infectieuses de la grossesse</term>
<term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Databases, Factual</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Pregnancy</term>
<term>Pregnant Women</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Vaccination</term>
<term>Vaccination Coverage</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Bases de données factuelles</term>
<term>Couverture vaccinale</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Femmes enceintes</term>
<term>Grossesse</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Vaccination</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Based on previous observations during pandemics and seasonal epidemics, pregnant women are considered at risk of developing severe influenza outcomes after influenza infection. With the aim of preventing severe influenza illness, the World Health Organization (WHO) includes pregnant women as a target group for seasonal influenza vaccination. However, influenza vaccine uptake during pregnancy remains low in many countries, including Spain. The objectives of this study were to increase the evidence of pregnancy as a risk factor for severe influenza illness and to study the potential role of seasonal influenza vaccination in the prevention of severe outcomes in infected pregnant women. Using information from the surveillance of Severe Hospitalized Confirmed Influenza Cases (SHCIC) in Spain, from seasons 2010/11 to 2015/16, we estimated that pregnant women in our study had a relative risk of hospitalization with severe influenza nearly 7.8 times higher than non-pregnant women of reproductive age. Only 5 out of 167 pregnant women with known vaccination status in our study had been vaccinated (3.6%). Such extremely low vaccination coverage only allowed obtaining crude estimates suggesting a protective effect of the vaccine against influenza complications (ICU admission or death). Our overall results support that pregnant women could benefit from seasonal influenza vaccination, in line with national and international recommendations.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30089148</PMID>
<DateCompleted><Year>2019</Year>
<Month>02</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>02</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>13</Volume>
<Issue>8</Issue>
<PubDate><Year>2018</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.</ArticleTitle>
<Pagination><MedlinePgn>e0200934</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0200934</ELocationID>
<Abstract><AbstractText>Based on previous observations during pandemics and seasonal epidemics, pregnant women are considered at risk of developing severe influenza outcomes after influenza infection. With the aim of preventing severe influenza illness, the World Health Organization (WHO) includes pregnant women as a target group for seasonal influenza vaccination. However, influenza vaccine uptake during pregnancy remains low in many countries, including Spain. The objectives of this study were to increase the evidence of pregnancy as a risk factor for severe influenza illness and to study the potential role of seasonal influenza vaccination in the prevention of severe outcomes in infected pregnant women. Using information from the surveillance of Severe Hospitalized Confirmed Influenza Cases (SHCIC) in Spain, from seasons 2010/11 to 2015/16, we estimated that pregnant women in our study had a relative risk of hospitalization with severe influenza nearly 7.8 times higher than non-pregnant women of reproductive age. Only 5 out of 167 pregnant women with known vaccination status in our study had been vaccinated (3.6%). Such extremely low vaccination coverage only allowed obtaining crude estimates suggesting a protective effect of the vaccine against influenza complications (ICU admission or death). Our overall results support that pregnant women could benefit from seasonal influenza vaccination, in line with national and international recommendations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mazagatos</LastName>
<ForeName>Clara</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0002-6909-6923</Identifier>
<AffiliationInfo><Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Delgado-Sanz</LastName>
<ForeName>Concepción</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Oliva</LastName>
<ForeName>Jesús</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gherasim</LastName>
<ForeName>Alin</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Larrauri</LastName>
<ForeName>Amparo</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Centre of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>Spanish Influenza Surveillance System</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>08</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D037841" MajorTopicYN="N">Pregnant Women</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>12</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>07</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>2</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30089148</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0200934</ArticleId>
<ArticleId IdType="pii">PONE-D-17-44513</ArticleId>
<ArticleId IdType="pmc">PMC6082521</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet. 2009 Aug 8;374(9688):451-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19643469</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2005 Apr;192(4):1098-106</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15846187</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2013 Jul;57(2):167-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23532475</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(8):e41638</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22870239</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Vaccines. 2016;15(3):425-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26690376</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2010 Oct 05;5(10):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20957195</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BJOG. 2015 Jan;122(1):17-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25040307</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Jan 24;368(4):333-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23323868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin. 2011 May;7(5):557-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21441784</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Clin (Barc). 2010 Feb 13;134(4):146-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19942237</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2016 May 19;11(5):e0154970</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27196667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 1998 Dec 1;148(11):1094-102</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9850132</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 Feb;58(4):449-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24280090</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2010 Jan 7;362(1):27-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20032319</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rev Med Virol. 2013 Jan;23(1):3-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22411229</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prev Med. 2013 Sep;57(3):206-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23732251</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 Sep 4;371(10):918-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25184864</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 2012 Jul;140(7):1316-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21920067</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2008 Jan;14(1):95-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18258087</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BJOG. 2011 Sep;118(10):1216-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21585645</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Aug 24;35(36):4811-4816</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28818474</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2011 Jun 14;342:d3214</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21672992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2011 Jul;205(1):10-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21345415</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Jan 23;35(4):521-528</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28024955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2012 Oct;206(8):1260-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22859826</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2009 Dec 17;14(50):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20070939</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obstet Gynecol. 2010 Apr;115(4):717-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20308830</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2010 Mar 18;340:c1279</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20299694</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Curr. 2010 Mar 09;2:RRN1150</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20228857</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2018 Jan;12(1):13-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29143498</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Clin (Barc). 2010 Oct 16;135(12):543-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20673677</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23210147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2010 Apr 21;303(15):1517-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20407061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CMAJ. 2007 Feb 13;176(4):463-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17296958</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2011 Jul;8(7):e1001053</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21750667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 May 20;15(20):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20504388</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2008 Jan;8(1):44-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18156088</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Matern Fetal Neonatal Med. 2011 Mar;24(3):402-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20593974</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2014 Apr 24;19(16):20780</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24786262</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S13-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21333967</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2018 May 31;36(23):3315-3322</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29706294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Jpn J Infect Dis. 2014;67(3):163-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24858604</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Public Health. 2016 Nov 21;16(1):1173</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27871262</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Oct 13;35(43):5738-5750</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28867508</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2015 Nov 25;33(47):6430-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26319740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Gynaecol Obstet. 2016 Feb;132(2):146-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26813261</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 1959 Dec;78:1172-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13824729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2018 Jan;12(1):161-170</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28960828</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 2011 Oct;139(10):1560-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21108872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2009 Oct 22;14(42):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19883549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Communauté de Madrid</li>
</region>
<settlement><li>Madrid</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Mazagatos, Clara" sort="Mazagatos, Clara" uniqKey="Mazagatos C" first="Clara" last="Mazagatos">Clara Mazagatos</name>
</region>
<name sortKey="Delgado Sanz, Concepci N" sort="Delgado Sanz, Concepci N" uniqKey="Delgado Sanz C" first="Concepci N" last="Delgado-Sanz">Concepci N Delgado-Sanz</name>
<name sortKey="Delgado Sanz, Concepci N" sort="Delgado Sanz, Concepci N" uniqKey="Delgado Sanz C" first="Concepci N" last="Delgado-Sanz">Concepci N Delgado-Sanz</name>
<name sortKey="Gherasim, Alin" sort="Gherasim, Alin" uniqKey="Gherasim A" first="Alin" last="Gherasim">Alin Gherasim</name>
<name sortKey="Gherasim, Alin" sort="Gherasim, Alin" uniqKey="Gherasim A" first="Alin" last="Gherasim">Alin Gherasim</name>
<name sortKey="Larrauri, Amparo" sort="Larrauri, Amparo" uniqKey="Larrauri A" first="Amparo" last="Larrauri">Amparo Larrauri</name>
<name sortKey="Larrauri, Amparo" sort="Larrauri, Amparo" uniqKey="Larrauri A" first="Amparo" last="Larrauri">Amparo Larrauri</name>
<name sortKey="Mazagatos, Clara" sort="Mazagatos, Clara" uniqKey="Mazagatos C" first="Clara" last="Mazagatos">Clara Mazagatos</name>
<name sortKey="Oliva, Jesus" sort="Oliva, Jesus" uniqKey="Oliva J" first="Jesús" last="Oliva">Jesús Oliva</name>
<name sortKey="Oliva, Jesus" sort="Oliva, Jesus" uniqKey="Oliva J" first="Jesús" last="Oliva">Jesús Oliva</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000066 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000066 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30089148
   |texte=   Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30089148" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021

	Serveur d'exploration sur la grippe en Espagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Espagne

Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.

Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki